These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21418093)

  • 1. The cost of universal screening for gestational diabetes mellitus in Ireland.
    Gillespie P; O'Neill C; Avalos G; O'Reilly M; Dunne F;
    Diabet Med; 2011 Aug; 28(8):912-8. PubMed ID: 21418093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New estimates of the costs of universal screening for gestational diabetes mellitus in Ireland.
    Gillespie P; O'Neill C; Avalos G; Dunne FP;
    Ir Med J; 2012 May; 105(5 Suppl):15-8. PubMed ID: 22838102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of costs and benefits of management of gestational diabetes mellitus.
    Kitzmiller JL; Elixhauser A; Carr S; Major CA; de Veciana M; Dang-Kilduff L; Weschler JM
    Diabetes Care; 1998 Aug; 21 Suppl 2():B123-30. PubMed ID: 9704239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening uptake rates and the clinical and cost effectiveness of screening for gestational diabetes mellitus in primary versus secondary care: study protocol for a randomised controlled trial.
    O'Dea A; Infanti JJ; Gillespie P; Tummon O; Fanous S; Glynn LG; McGuire BE; Newell J; Dunne FP
    Trials; 2014 Jan; 15():27. PubMed ID: 24438478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of screening for gestational diabetes mellitus in primary and secondary care in the Republic of Ireland.
    Danyliv A; Gillespie P; O'Neill C; Tierney M; O'Dea A; McGuire BE; Glynn LG; Dunne FP
    Diabetologia; 2016 Mar; 59(3):436-44. PubMed ID: 26670162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of costs associated with screening for gestational diabetes with two-tiered and one-tiered testing protocols.
    Lavin JP; Lavin B; O'Donnell N
    Am J Obstet Gynecol; 2001 Feb; 184(3):363-7. PubMed ID: 11228488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gestational diabetes: universal or selective screening?
    Alberico S; Strazzanti C; De Santo D; De Seta F; Lenardon P; Bernardon M; Zicari S; Guaschino S
    J Matern Fetal Neonatal Med; 2004 Dec; 16(6):331-7. PubMed ID: 15621551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel.
    Marseille E; Lohse N; Jiwani A; Hod M; Seshiah V; Yajnik CS; Arora GP; Balaji V; Henriksen O; Lieberman N; Chen R; Damm P; Metzger BE; Kahn JG
    J Matern Fetal Neonatal Med; 2013 May; 26(8):802-10. PubMed ID: 23311860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atlantic DIP: the prevalence and consequences of gestational diabetes in Ireland.
    O'Sullivan EP; Avalos G; O'Reilly M; Dennedy MC; Gaffney G; Dunne FP;
    Ir Med J; 2012 May; 105(5 Suppl):13-5. PubMed ID: 22838101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term effects of gestational diabetes mellitus on healthcare cost: a cross-sectional comparative study in the ATLANTIC DIP cohort.
    Danyliv A; Gillespie P; O'Neill C; Noctor E; O'Dea A; Tierney M; McGuire B; Glynn LG; Dunne F
    Diabet Med; 2015 Apr; 32(4):467-76. PubMed ID: 25529506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus.
    Lohse N; Marseille E; Kahn JG
    Int J Gynaecol Obstet; 2011 Nov; 115 Suppl 1():S20-5. PubMed ID: 22099435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gestational diabetes mellitus: time for consensus on screening and diagnosis.
    Simmons D; Wolmarans L; Cutchie W; Johnson E; Haslam A; Roodt C; Rowan J
    N Z Med J; 2006 Jan; 119(1228):U1807. PubMed ID: 16462918
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and cost of postpartum screening strategies for diabetes among women with histories of gestational diabetes mellitus.
    Kim C; Herman WH; Vijan S
    Diabetes Care; 2007 May; 30(5):1102-6. PubMed ID: 17322480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gestational diabetes mellitus screening and diagnosis: a prospective randomised controlled trial comparing costs of one-step and two-step methods.
    Meltzer SJ; Snyder J; Penrod JR; Nudi M; Morin L
    BJOG; 2010 Mar; 117(4):407-15. PubMed ID: 20105163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of gestational diabetes mellitus screening in France.
    Poncet B; Touzet S; Rocher L; Berland M; Orgiazzi J; Colin C
    Eur J Obstet Gynecol Reprod Biol; 2002 Jul; 103(2):122-9. PubMed ID: 12069733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic criteria for gestational diabetes: The debate goes on.
    Durán Rodriguez-Hervada A; Calle Pascual AL
    Endocrinol Nutr; 2015 May; 62(5):207-9. PubMed ID: 25842036
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening for gestational diabetes in Sicily.
    Corrado F; Stella NC; Mancuso A; Triolo O; Bruno L; Artenisio AC
    J Reprod Med; 1999 Oct; 44(10):875-8. PubMed ID: 10554749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global cost-effectiveness of GDM screening and management: current knowledge and future needs.
    Weile LK; Kahn JG; Marseille E; Jensen DM; Damm P; Lohse N
    Best Pract Res Clin Obstet Gynaecol; 2015 Feb; 29(2):206-24. PubMed ID: 25225056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland.
    Gillespie P; O'Neill C; Adams E; Turner K; O'Donovan D; Brugha R; Vaughan D; O'Connell E; Cormican M; Balfe M; Coleman C; Fitzgerald M; Fleming C
    Sex Transm Infect; 2012 Apr; 88(3):222-8. PubMed ID: 22213681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring Structural Uncertainty in Cost-Effectiveness Modeling of Gestational Diabetes Screening: An Application Example from Norway.
    Henkel PS; Burger EA; Sletner L; Pedersen K
    Med Decis Making; 2024 May; 44(4):380-392. PubMed ID: 38591188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.